Displaying drugs 101 - 125 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Ramucirumab | 143600.0 C6374H9864N1692O1996S46 |  | An antineoplastic agent and direct VEGFR2 (vascular endothelial growth factor receptor 2) antagonist that blocks the binding of natural VEGF ligands, which are secreted by solid tumors to promote angiogenesis and enhance tumor blood supply. | Angiogenesis Inhibitors / Antibodies, Monoclonal / VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors |
| Rabies immune globulin, human | Not Available |  | A solution of antibodies used to prevent rabies after an exposure. | Human Rabies Immune Globulins / Serum / Vaccines |
| Pucotenlimab | Not Annotated | | Pucotenlimab is a recombinant humanized anti-PD-1 monoclonal antibody. It received its first global approval in China in July 2022 for the treatment of solid tumours. It is being investigated in... | Not Annotated |
| Prothrombin | Not Available | | A coagulation factor used for emergency reversal of vitamin K antagonist therapy. | Blood Coagulation Factors / Enzyme Precursors / Prothrombin, agonists |
| Protein S human | 75123.0 |  | A medication used for emergency reversal of coagulation factor deficiency in vitamin K antagonist therapy. | Anticoagulants / Blood Coagulation Factor Inhibitors / Blood Proteins / Glycoproteins |
| Protein C | Not Available |  | A medication used to treat protein C deficiency leading to purpura fulminans or coumarin-induced skin necrosis. | Enzymes |
| Protamine sulfate | Not Available | | A blood factor used when the reversal of the anticoagulant effect of heparin is necessary and for the treatment of heparin overdose. | Heparin Antagonists / Heparin Reversal Agent / Nuclear Proteins / Nucleoproteins |
| Poractant alfa | Not Available | | A pulmonary surfactant used for the treatment of Respiratory Distress Syndrome (RDS) in premature infants. | Pulmonary Surfactants / Surface-Active Agents |
| Polatuzumab vedotin | 150000.0 C6670H10317N1745O2087S40 | | A CD79b antibody conjugate indicated to treat different types of large B-cell lymphoma. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antibody-drug Conjugates / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Blood Proteins / Cancer immunotherapy / CD79b-directed Antibody–Drug Conjugates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Substrates / Globulins / Immunoglobulins / Immunologic Factors / Immunoproteins / Immunotherapy / MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES / Noxae / P-glycoprotein substrates / Proteins / Serum Globulins / Toxic Actions |
| Plasminogen | Not Available | | Plasma-derived human plasminogen administered intravenously to treat type 1 plasminogen deficiency (hypoplasminogenemia). | Anticoagulants / Beta-Globulins / Enzyme Precursors / Fibrinolytic Agents |
| Plasma protein fraction (human) | Not Available | | A plasma protein solution used to treat coagulation factor deficiencies, reverse anticoagulant effects, and shock from a loss of plasma fluids, and is also used in plasma exchange procedures. | Plasma Substitutes |
| Pertuzumab | 148000.0 |  | An antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents. | Antibodies, Monoclonal / HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors |
| Pepsin | Not Available | | A protease indicated in the treatment of digestive disorders. | Enzyme Preparations |
| Pembrolizumab | 149000.0 C6504H10004N1716O2036S46 |  | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. | Antibodies, Monoclonal / PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| Pegvisomant | 22129.0 C990H1532N262O300S7 |  | A growth hormone receptor antagonist used to treat acromegaly. | Acromegaly / Growth Hormone Receptor Antagonist |
| Pegunigalsidase alfa | 116000.0 C2060H3130N552O601S27 | | A recombinant form of human α-galactosidase-A indicated for long-term enzyme replacement therapy in patients with Fabry disease. | Enzymes |
| Pegloticase | 34192.8533 C1549H2430N408O448S8 | | A recombinant uricase used for the treatment of chronic gout in adult patients refractory to conventional therapy. | Uric Acid-specific Enzyme |
| Peginterferon beta-1a | 22500.0 | | An interferon beta used to treat relapsing forms of multiple sclerosis. | Interferon-beta / Interferons |
| Peginterferon alfa-2b | 31000.0 |  | A purified form of human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C, genital warts, and some cancers. | Antiviral Agents / Drug Carriers / Hepatitis C / Interferon alpha / Interferons |
| Peginterferon alfa-2a | 60000.0 |  | A modified form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. | Antiviral Agents / Drug Carriers / Interferon alpha / Interferons |
| Peginesatide | Not Available | | Peginesatide is used for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis | Erythropoiesis-Stimulating Agents |
| Pegfilgrastim | 39000.0 C845H1343N223O243S9 |  | A recombinant human granulocyte colony stimulating factor used to stimulate the production of neutrophils and prevent febrile neutropenia or infections after myelosuppressive chemotherapy. | Colony-Stimulating Factors |
| Pegaspargase | 31731.9 C1377H2208N382O442S17 |  | A modified form of L-asparagine amidohydrolase used to treat acute lymphoblastic leukemia, which is dependent on an external source of asparagine. | Asparagine-specific Enzyme / Delayed-Action Preparations |
| Pegademase | 40788.2 C1821H2834N484O552S14 |  | A modified form of bovine adenosine deaminase used to treat adenosine deaminase deficiency, a condition which leads to the formation of adenosine metabolites which are cytotoxic to lymphocytes. | Bovine Intestinal Adenosine Deaminase / Severe Combined Immunodeficiency |
| Parathyroid hormone | 9420.0 C408H674N126O126S2 |  | An analog of human parathyroid hormone (PTH) used to treat hypocalcemia caused by hypoparathyroidism. | Parathyroid Hormones and Analogues |
Displaying drugs 101 - 125 of 406 in total